Page last updated: 2024-08-17

ampicillin and resiquimod

ampicillin has been researched along with resiquimod in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annunziato, F; Brugnolo, F; Campi, P; Cosmi, L; Liotta, F; Maggi, E; Manuelli, C; Parronchi, P; Romagnani, S; Sampognaro, S1
Abt, MC; Artis, D; Becattini, S; Buffie, CG; Carter, RA; Keith, JW; Leiner, I; Osborne, LC; Pamer, EG; SuĊĦac, B1

Other Studies

2 other study(ies) available for ampicillin and resiquimod

ArticleYear
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.
    The Journal of allergy and clinical immunology, 2003, Volume: 111, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Allergens; Ampicillin; Animals; Antigens, Dermatophagoides; Arthropod Proteins; Cell Line; Cysteine Endopeptidases; Cytokines; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Imidazoles; In Vitro Techniques; Interferon-gamma; Models, Immunological; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells

2003
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.
    Science translational medicine, 2016, Feb-24, Volume: 8, Issue:327

    Topics: Ampicillin; Animals; Caliciviridae Infections; CD11c Antigen; Colony Count, Microbial; Dendritic Cells; Drug Resistance, Bacterial; Enterococcus; Gastroenteritis; Imidazoles; Interferon Type I; Interleukin-1; Interleukin-22; Interleukin-23; Interleukins; Ligands; Mice, Inbred C57BL; Norovirus; Pancreatitis-Associated Proteins; Proteins; Signal Transduction; Toll-Like Receptor 7; Vancomycin

2016